Antengene Announces IND Approval for the Phase I STAMINA-001 Study to Evaluate ATG-037 (CD73 Inhibitor) for the Treatment of Locally Advanced or Metastatic Solid Tumors in China. Dr Amit Kakar joins MedGenome Board of Directors BANGALORE, India, Wed, Nov 2 2022 10:00 AM The company has also added Navjeewan Khosla from Novo Holdings as Board Observer. | PR Newswire
Caring for your hearing health is essential regardless of your age. Not only does it reduce the risk of suffering from irreversible hearing loss... Read More
Sunway Healthcare Group (Sunway Healthcare) is set to launch its flagship senior living residence in response to increasing... Read More
The World Health Organisation (WHO) has mentioned that diabetes claims about three lives every minute worldwide – to narrow it down diabetes has been found to affect over 1 in 5 Malaysians... Read More
The prevalence of breast cancer is expected to cause more than 2.5 million deaths between 2020 and 2040, if nothing is done to avert it... Read More
Type 1 diabetes mellitus mostly afflicts young children – it is apparently the most common form of childhood diabetes in Malaysia... Read More